<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/183</identifier>
				<datestamp>2024-10-30T18:55:24Z</datestamp>
				<setSpec>aavptbiennial:S8</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Drugs Used to Treat Cardiovascular Disease in Horses</dc:title>
	<dc:creator xml:lang="en">Muir, W. W.</dc:creator>
	<dc:creator xml:lang="en">Sams, R. A.</dc:creator>
	<dc:subject xml:lang="en">cardiovascular disease</dc:subject>
	<dc:subject xml:lang="en">equine medicine</dc:subject>
	<dc:subject xml:lang="en">drugs</dc:subject>
	<dc:subject xml:lang="en">atrial fibrillation</dc:subject>
	<dc:subject xml:lang="en">digitalis glycosides</dc:subject>
	<dc:subject xml:lang="en">diuretics</dc:subject>
	<dc:subject xml:lang="en">antiarrhythmic drugs</dc:subject>
	<dc:description xml:lang="en">The treatment of cardiovascular disease in the horse has evolved considerably over the past ten years. Diseases involving the cardiovascular system of horses, which were once considered nontreatable, are now being diagnosed and treated routinely in many progressive equine practices. Common cardiovascular diseases of the horse include a variety of cardiac arrhythmias, particularly atrial fibrillation, acquired heart disease and congenital heart disease. Table 1 lists the common cardiovascular diseases observed in horses in the United States.
The drugs used for the treatment of cardiovascular disease in horses are principally agents which are designed to improve the quality of life, not necessarily prolong life. Towards this end digitalis glycosides, diuretics and a variety of antiarrhythmic drugs have been advocated. The digitalis glycosides, particularly digoxin, have been extensively studied and are frequently used clinically to treat cardiovascular failure in horses. Table 2 lists pharmacokinetic data reported by various investigators for digoxin in horses.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1984-04-25</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/183</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Fourth Symposium; 222-230</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/183/175</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1984 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
